[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100580153":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":21,"responsibleParty":75,"collaborators":10,"id":77,"slug":10,"hasResults":78,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":82,"eligibilityCriteria":83,"healthyVolunteers":78,"sex":84,"minAge":85,"maxAge":10,"enrollmentInfo":86,"targetDuration":10,"studyType":89,"phases":10,"briefSummary":90,"conditions":91,"keywords":95,"overallStatus":24,"whyStopped":10,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":109},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Adult with Enterococcus faecalis monomicrobial bloodstream infection",null,"Adult patients with primary Enterococcus faecalis monomicrobial bloodstream infection",[13],{"name":14,"affiliation":5,"role":15},"Maddalena Giannella, MD PhD","PRINCIPAL_INVESTIGATOR",[17],{"name":14,"role":18,"phone":19,"phoneExt":10,"email":20},"CONTACT","+39 0512143199","maddalena.giannella@unibo.it",[22,39,46,60],{"facility":23,"status":24,"city":25,"state":25,"zip":26,"country":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"Ospedale Maggiore \"Carlo Alberto Pizzardi\" di Bologna","RECRUITING","Bologna","40133","Italy",{"type":29,"coordinates":30},"Point",[31,32],11.33875,44.49381,{"lat":32,"lon":31},[35],{"name":36,"role":18,"phone":37,"phoneExt":10,"email":38},"Luca Guerra, MD","+390515879975","luca.guerra@ausl.bologna.it",{"facility":5,"status":24,"city":25,"state":25,"zip":40,"country":27,"cosmosGeoPoint":41,"geoPoint":43,"contacts":44},"40138",{"type":29,"coordinates":42},[31,32],{"lat":32,"lon":31},[45],{"name":14,"role":18,"phone":19,"phoneExt":10,"email":20},{"facility":47,"status":24,"city":48,"state":48,"zip":49,"country":27,"cosmosGeoPoint":50,"geoPoint":54,"contacts":55},"Azienda Ospedaliero Universitaria di Catanzaro \"Mater Domini\"","Catanzaro","88100",{"type":29,"coordinates":51},[52,53],16.60086,38.88247,{"lat":53,"lon":52},[56],{"name":57,"role":18,"phone":58,"phoneExt":10,"email":59},"Alessandro Russo, MD","+3909613647552","a.russo@unicz.it",{"facility":61,"status":24,"city":62,"state":63,"zip":64,"country":27,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"Humanitas Research Hospital","Milan","Milano","20089",{"type":29,"coordinates":66},[67,68],12.59836,42.78235,{"lat":68,"lon":67},[71],{"name":72,"role":18,"phone":73,"phoneExt":10,"email":74},"Michele Bartoletti, MD","+390282243568","michele.bartoletti@hunimed.eu",{"type":76,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100580153",false,"NCT06833593","Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia","Efficacy of Optimized Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia and Identification of Intestinal Microbiota Signature","MicroEFfAECT","Inclusion Criteria:\n\n* Adult (≥18 years)\n* Monomicrobial EF-BSI\n* Receipt of ≥ 5 days of at least one in vitro active drug (ampicillin, amoxicillin\u002Fclavulanate, ampicillin\u002Fsulbactam, piperacillin, vancomycin, teicoplanin, daptomycin and linezolid) with or without a synergistic drug (ceftriaxone, gentamycin, streptomycin), at common suggested dosages for EF-BSI in empirical or definitive therapy\n* Written informed consent\n\nExclusion Criteria:\n\n* Short term (within 3 days from BSI) mortality\n* Other concomitant infection","ALL","18 Years",{"count":87,"type":88},510,"ESTIMATED","OBSERVATIONAL","Prospective, multicenter, national, observational pharmacological study on the evaluation of efficacy of appropriate monotherapy vs combination treatment for non-complicated Enterococcus faecalis (EF) bloodstream infection (BSI) and identification of gut microbiota fingerprint of patients with EF-BSI correlated to antimicrobial treatment and clinical outcome",[92,93,94],"Enterococcus Faecalis Infection","Blood Stream Infection","Gut Microbiomes",[96,97,98,99],"Enterococcus faecalis bloodstream infection","Human tissue analysis in vitro","Gut microbiota analysis","Enterococcus faecalis genomic analysis","2025-11-26",{"date":102,"type":103},"2025-12-03","ACTUAL",{"date":105,"type":103},"2021-02-06",{"date":107,"type":88},"2026-09-26",{"name":5,"class":6},4]